According to filings with the U.S. Securities and Exchange Commission, BEKHealth is raising up to $4,624,176.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, David Levin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About BEKHealth
Purpose-built for organizations conducting clinical trials and observational studies, we leverage our AI-powered patient-matching platform and clinical expertise to optimize feasibility and speed up patient identification by extracting structured and unstructured data from electronic medical records (EMRs) that captures three times more trial criteria. Why: We believe sites are vital to the success of clinical trials. Empowering them to find the right patient for the right research at the right time is the focus of everything we do. What: We leverage our best-in-class technology and data expertise to detect more protocol-eligible candidates than traditional methods, so that site teams can focus on the parts of the job they actually love. How: We deliver an AI-powered software platform and support from clinical experts that enables our customers to find and match patients to available clinical research. With unbelievably fast and highly-accurate data extraction from electronic medical records (EMRs) we can capture three times more trial criteria – making trial participation more accessible and efficient.

To learn more about BEKHealth, visit http://www.bekhealth.com/
BEKHealth Linkedin Page: https://www.linkedin.com/company/bekhealth/

Contact:
David Levin, Chief Executive Officer
551-265-8778
https://www.linkedin.com/in/davidshanelevin/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.